作者
Mengyang Di, Chen Mao, Zuyao Yang, Hong Ding, Qu Liu, Shuiming Liu, Hongbo Guo, Kunhua Jiang, Jinling Tang
发表日期
2020/6/1
期刊
BMJ Evidence-Based Medicine
卷号
25
期号
3
页码范围
102-108
出版商
Royal Society of Medicine
简介
Objective
To evaluate whether evidence-based, individualised (EBI) counselling regarding hypertension and the treatment would affect medication use in insured patients with mild hypertension in China.
Methods
We conducted a parallel-group, randomised controlled trial in two primary care centres in Shenzhen, a metropolitan city in China. Patients with mild primary hypertension, 10-year risk of cardiovascular diseases (CVDs) lower than 20% and no history of CVDs were recruited and randomly allocated to two groups. EBI plus general counselling was provided to the intervention group and general counselling alone to the control group. EBI counselling included information on the 10-year CVD risk and treatment benefit in terms of absolute risk reduction estimated for each individual and information on average side effects and costs of antihypertensive drugs. The outcomes included use of antihypertensive drugs …
引用总数
2020202120222023202412111